Financials
- Market Capitalization 1.13 B
- Employee 260
- Founded 2014
- CEO N/A
- Website www.kuraoncology.com
- Headquarter Delaware, United States
- FIGI BBG008974342
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-3.27
ratio cours/chiffre d'affaires
13.5
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 2355 | SANA Sana Biotechnology, Inc. - Common Stock | 3.93 USD | -3.91% | +1.29% | +23.97% | +30.56% | 1.18 B USD | ||
| 2371 | GLUE Monte Rosa Therapeutics, Inc. - Common Stock | 13.38 USD | -6.56% | -4.56% | -39.43% | +18.41% | 1.14 B USD | ||
| 2402 | JANX Janux Therapeutics, Inc. - Common Stock | 18.03 USD | -3.99% | +1.86% | +21.17% | -21.13% | 1.10 B USD | ||
| 2414 | SVRA Savara, Inc. - Common Stock | 5.26 USD | -4.19% | -6.07% | -4.01% | +60.37% | 1.08 B USD |